Related Experiment Video
Updated: Dec 23, 2025
07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
17.8K
Alpha-1 Antitrypsin Deficiency and Pregnancy
Nate T Gaeckle1, Laurel Stephenson1, Ronald A Reilkoff1
1Department of Pulmonary, Critical Care and Sleep Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
COPD
|April 21, 2020
Summary
Alpha-1 Antitrypsin Deficiency (A1AD) affects pregnant women, potentially causing lung disease. Management relies on expert opinion due to limited research on A1AD and pregnancy, emphasizing individualized care.
Area of Science:
- Pulmonology
- Genetics
- Obstetrics
Background:
- Alpha-1 Antitrypsin Deficiency (A1AD) is an inherited condition causing low alpha-antitrypsin (AAT) levels.
- A1AD is a primary genetic risk factor for chronic obstructive pulmonary disease (COPD).
- A1AD diagnosis is often missed, even in young individuals, including pregnant women who may present with advanced lung disease.
Observation:
- Reduced AAT levels may present unique challenges for pregnant patients beyond lung disease.
- Managing pregnant patients with A1AD and lung disease involves standard airway disease care.
- Treatment goals include symptom control and minimizing exacerbation risk.
Findings:
- The impact of A1AD and AAT augmentation during pregnancy is not well-studied.
- Current care practices rely on expert opinion and clinical experience.
- A case review of a pregnant A1AD patient is presented.
Implications:
- Healthcare providers should refer pregnant A1AD patients to specialized A1AD centers.
- Patients and physicians must individually weigh the risks and benefits of continuing or stopping therapies.
- Further research is needed to understand AAT augmentation in pregnancy.
Related Concept Videos
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
816
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
816
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
01:20Inborn Errors of Metabolism
627
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
627
01:19Rh Blood Group
2.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.6K
01:24Cystic Fibrosis: Management
378
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
378